Laurence Katznelson

Publications

• American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly--2011 update: executive summary. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK. Endocr Pract. 2011 Jul-Aug; 17 (4): 636-46
• Sustained Improvements in Plasma ACTH and Clinical Status in a Patient With Nelson's Syndrome Treated With Pasireotide LAR, a Multireceptor Somatostatin Analog. Katznelson L, J Clin Endocrinol Metab. 2013; 98 (5): 1803-7
• Pituitary centers of excellence. McLaughlin N, Laws ER, Oyesiku NM, Katznelson L, Kelly DF. Neurosurgery. 2012; 71 (5): 916-24; discussion 924-6
• American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly--2011 update. Katznelson L, Atkinson JL, Cook DM, Ezzat SZ, Hamrahian AH, Miller KK. Endocr Pract. 2011 Jul-Aug: 17 Suppl 4 1-44
• Ectopic acromegaly due to a pancreatic neuroendocrine tumor producing growth hormone-releasing hormone. Weiss DE, Vogel H, Lopes MB, Chang SD, Katznelson L. Endocr Pract. 2011 Jan-Feb; 17 (1): 79-84
• The dynamics of post-operative plasma ACTH values following transsphenoidal surgery for Cushing's disease. Srinivasan L, Laws ER, Dodd RL, Monita MM, Tannenbaum CE, Kirkeby KM, Chu OS, Harsh GR, Katznelson L. Pituitary. 2011; 14 (4): 312-7
• Retrosellar intracranial extracerebral glioneuronal heterotopion: case report. Karamchandani J, Fischbein N, Harsh G, Katznelson L, Vogel H. Clin Neuropathol. 2010 Sep-Oct; 29 (5): 297-300
• A novel PRKAR1A mutation associated with primary pigmented nodular adrenocortical disease and the Carney complex. Peck MC, Visser BC, Norton JA, Pasche L, Katznelson L. Endocr Pract. 2010 Mar-Apr; 16 (2): 198-204
• Approach to the patient with persistent acromegaly after pituitary surgery. Katznelson L, J Clin Endocrinol Metab. 2010; 95 (9): 4114-23
• Alterations in body composition in acromegaly. Katznelson L, Pituitary. 2009; 12 (2): 136-42
• Endogenous NIS expression in triple-negative breast cancers. Renier C, Yao C, Goris M, Ghosh M, Katznelson L, Nowles K, Gambhir SS, Wapnir I. Ann Surg Oncol. 2009; 16 (4): 962-8
• Lanreotide promotes apoptosis and is not radioprotective in GH3 cells. Ning S, Knox SJ, Harsh GR, Culler MD, Katznelson L. Endocr Relat Cancer. 2009; 16 (3): 1045-55
• Non-surgical management of hormone-secreting pituitary tumors. Patil CG, Hayden M, Katznelson L, Chang SD. J Clin Neurosci. 2009; 16 (8): 985-93
• Prevalence and clinical demographics of cerebral salt wasting in patients with aneurysmal subarachnoid hemorrhage. Kao L, Al-Lawati Z, Vavao J, Steinberg GK, Katznelson L. Pituitary. 2009; 12 (4): 347-51
• The impact of hypopituitarism on function and performance in subjects with recent history of traumatic brain injury and aneurysmal subarachnoid haemorrhage. Srinivasan L, Roberts B, Bushnik T, Englander J, Spain DA, Steinberg GK, Ren L, Sandel ME, Al-Lawati Z, Teraoka J, Hoffman AR, Katznelson L. Brain Inj. 2009; 23 (7): 639-48
• An update on treatment strategies for acromegaly. Katznelson L, Expert Opin Pharmacother. 2008; 9 (13): 2273-80
• Late recurrences of Cushing's disease after initial successful transsphenoidal surgery. Patil CG, Prevedello DM, Lad SP, Vance ML, Thorner MO, Katznelson L, Laws ER. J Clin Endocrinol Metab. 2008; 93 (2): 358-62
• Outcomes after repeat transsphenoidal surgery for recurrent Cushing's disease. Patil CG, Veeravagu A, Prevedello DM, Katznelson L, Vance ML, Laws ER. Neurosurgery. 2008; 63 (2): 266-70; discussion 270-1
• Reninoma: case report and literature review. Wong L, Hsu TH, Perlroth MG, Hofmann LV, Haynes CM, Katznelson L. J Hypertens. 2008; 26 (2): 368-73
• Use of high-dose oral bisphosphonate therapy for symptomatic fibrous dysplasia of the skull. Chao K, Katznelson L. J Neurosurg. 2008; 109 (5): 889-92
• Approach to the evaluation of the GH/IGF-axis in patients with pituitary disease: which test to order. Roberts B, Katznelson L. Pituitary. 2007; 10 (2): 205-11
• Brain atrophy and cognitive deficits in Cushing's disease. Patil CG, Lad SP, Katznelson L, Laws ER. Neurosurg Focus. 2007; 23 (3): E11
• Current thinking on the management of the acromegalic patient. Katznelson L, Curr Opin Endocrinol Diabetes Obes. 2007; 14 (4): 311-6
• Efficacy and safety of CyberKnife radiosurgery for acromegaly. Roberts BK, Ouyang DL, Lad SP, Chang SD, Harsh GR, Adler JR, Soltys SG, Gibbs IC, Remedios L, Katznelson L. Pituitary. 2007; 10 (1): 19-25
• Pegvisomant for the treatment of acromegaly-translation of clinical trials into clinical practice. Katznelson L, Nat Clin Pract Endocrinol Metab. 2007; 3 (7): 514-5
• The role of inferior petrosal sinus sampling in the diagnostic localization of Cushing's disease. Lad SP, Patil CG, Laws ER, Katznelson L. Neurosurg Focus. 2007; 23 (3): E2
• Isolated Langerhans cell histiocytosis in an adult with central diabetes insipidus: case report and review of literature. Ouyang DL, Roberts BK, Gibbs IC, Katznelson L. Endocr Pract. 2006 Nov-Dec; 12 (6): 660-3
• Drug insight: Primary medical therapy of acromegaly. Katznelson L, Nat Clin Pract Endocrinol Metab. 2006; 2 (2): 109-17; quiz following 117
• Effects of modest testosterone supplementation and exercise for 12 weeks on body composition and quality of life in elderly men. Katznelson L, Robinson MW, Coyle CL, Lee H, Farrell CE. Eur J Endocrinol. 2006; 155 (6): 867-75
• Diagnosis and treatment of acromegaly. Katznelson L, Growth Horm IGF Res. 2005: 15 Suppl A S31-5
• Long-acting somatostatin analog therapy of acromegaly: a meta-analysis. Freda PU, Katznelson L, van der Lely AJ, Reyes CM, Zhao S, Rabinowitz D. J Clin Endocrinol Metab. 2005; 90 (8): 4465-73
• Diagnostic errors after inferior petrosal sinus sampling. Swearingen B, Katznelson L, Miller K, Grinspoon S, Waltman A, Dorer DJ, Klibanski A, Biller BM. J Clin Endocrinol Metab. 2004; 89 (8): 3752-63
• Effects of growth hormone secretion on body composition in patients with Crohn's disease. Katznelson L, Fairfield WP, Zeizafoun N, Sands BE, Peppercorn MA, Rosenthal DI, Klibanski A. J Clin Endocrinol Metab. 2003; 88 (11): 5468-72
• Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant. Sesmilo G, Fairfield WP, Katznelson L, Pulaski K, Freda PU, Bonert V, Dimaraki E, Stavrou S, Vance ML, Hayden D, Klibanski A. J Clin Endocrinol Metab. 2002; 87 (4): 1692-9
• Hypogonadism in patients with acromegaly: data from the multi-centre acromegaly registry pilot study. Katznelson L, Kleinberg D, Vance ML, Stavrou S, Pulaski KJ, Schoenfeld DA, Hayden DL, Wright ME, Woodburn CJ, Klibanski A, Stravou S. Clin Endocrinol (Oxf). 2001; 54 (2): 183-8
• Hypothalamic/pituitary function following high-dose conformal radiotherapy to the base of skull: demonstration of a dose-effect relationship using dose-volume histogram analysis. Pai HH, Thornton A, Katznelson L, Finkelstein DM, Adams JA, Fullerton BC, Loeffler JS, Leibsch NJ, Klibanski A, Munzenrider JE. Int J Radiat Oncol Biol Phys. 2001; 49 (4): 1079-92
• Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, Klibanski A, Herman-Bonert V, Melmed S, Vance ML, Freda PU, Stewart PM, Friend KE, Clemmons DR, Johannsson G, Stavrou S, Cook DM, Phillips LS, Strasburger CJ, Hackett S, Zib KA, Davis RJ, Scarlett JA, Thorner MO. Lancet. 2001; 358 (9295): 1754-9
• Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors. Danila DC, Haidar JN, Zhang X, Katznelson L, Culler MD, Klibanski A. J Clin Endocrinol Metab. 2001; 86 (7): 2976-81
• Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, Dimaraki EV, Stewart PM, Friend KE, Vance ML, Besser GM, Scarlett JA, Thorner MO, Parkinson C, Klibanski A, Powell JS, Barkan AL, Sheppard MC, Malsonado M, Rose DR, Clemmons DR, Johannsson G, Bengtsson BA, Stavrou S, Kleinberg DL, Cook DM, Phillips LS, Bidlingmaier M, Strasburger CJ, Hackett S, Zib K, Bennett WF, Davis RJ. N Engl J Med. 2000; 342 (16): 1171-7
• Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas. Katznelson L, Bogan JS, Trob JR, Schoenfeld DA, Hedley-Whyte ET, Hsu DW, Zervas NT, Swearingen B, Sleeper M, Klibanski A. J Clin Endocrinol Metab. 1998; 83 (5): 1619-23